Avricore Health (AVCRF) Current Deferred Revenue (2019 - 2022)

Avricore Health has disclosed Current Deferred Revenue across 3 years of filings, most recently posting $185649.1 for Q4 2022.

• In Q4 2022, Current Deferred Revenue changed N/A year-over-year to $185649.1; the TTM figure through Dec 2022 stood at $185649.1 (changed N/A YoY), while the FY2022 annual figure was $193829.9, changed N/A from the prior year.
• Current Deferred Revenue rose to $185649.1 in Q4 2022, from $31205.1 in the prior quarter.
• Over the last five years, Current Deferred Revenue for AVCRF reached as high as $185649.1 in Q4 2022 and fell as low as $7458.9 in Q1 2020.
• The 3-year median for Current Deferred Revenue is $9020.0 (2019), against an average of $41654.7.
• The widest YoY moves for Current Deferred Revenue: up 198.22% in 2020, down 198.22% in 2020.
• A 3-year view of Current Deferred Revenue shows it stood at $7575.0 in 2019, then jumped by 311.95% to $31205.1 in 2020, then soared by 494.93% to $185649.1 in 2022.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $185649.1, $31205.1, and $7458.9 for Q4 2022, Q2 2020, and Q1 2020 respectively.